MAXIMUS, Inc. (NYSE:MMS) insider Mark Andrekovich sold 7,795 shares of the business’s stock in a transaction that occurred on Friday, November 30th. The shares were sold at an average price of $70.42, for a total value of $548,923.90. Following the completion of the transaction, the insider now owns 19,272 shares of the company’s stock, valued at $1,357,134.24. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

NYSE:MMS opened at $70.74 on Thursday. MAXIMUS, Inc. has a twelve month low of $60.00 and a twelve month high of $72.71. The company has a market cap of $4.54 billion, a price-to-earnings ratio of 20.81, a PEG ratio of 1.93 and a beta of 1.03.

MAXIMUS (NYSE:MMS) last released its quarterly earnings results on Tuesday, November 20th. The health services provider reported $0.71 earnings per share for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). MAXIMUS had a return on equity of 20.23% and a net margin of 9.23%. The firm had revenue of $558.50 million for the quarter, compared to analyst estimates of $587.58 million. During the same period last year, the company earned $0.81 EPS. The company’s revenue was down 10.0% compared to the same quarter last year. Sell-side analysts expect that MAXIMUS, Inc. will post 3.66 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, November 30th. Shareholders of record on Thursday, November 15th were given a dividend of $0.25 per share. The ex-dividend date was Wednesday, November 14th. This represents a $1.00 dividend on an annualized basis and a yield of 1.41%. This is an increase from MAXIMUS’s previous quarterly dividend of $0.05. MAXIMUS’s dividend payout ratio is 29.41%.

Several equities analysts recently issued reports on the company. Zacks Investment Research upgraded MAXIMUS from a “sell” rating to a “hold” rating in a research report on Tuesday, August 14th. ValuEngine upgraded MAXIMUS from a “hold” rating to a “buy” rating in a research report on Friday, November 30th. Finally, Canaccord Genuity boosted their price objective on MAXIMUS from $64.00 to $67.00 and gave the company a “hold” rating in a research report on Wednesday, October 10th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $72.00.

A number of large investors have recently added to or reduced their stakes in MMS. Wells Fargo & Company MN boosted its position in MAXIMUS by 299.9% during the 2nd quarter. Wells Fargo & Company MN now owns 919,740 shares of the health services provider’s stock worth $57,124,000 after acquiring an additional 689,734 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of MAXIMUS by 6.5% in the 2nd quarter. BlackRock Inc. now owns 7,298,102 shares of the health services provider’s stock valued at $453,284,000 after buying an additional 445,353 shares during the last quarter. Epoch Investment Partners Inc. acquired a new stake in shares of MAXIMUS in the 3rd quarter valued at approximately $26,493,000. Thompson Siegel & Walmsley LLC boosted its holdings in shares of MAXIMUS by 54.5% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 979,701 shares of the health services provider’s stock valued at $60,849,000 after buying an additional 345,555 shares during the last quarter. Finally, Credit Suisse AG boosted its holdings in shares of MAXIMUS by 73.1% in the 3rd quarter. Credit Suisse AG now owns 703,332 shares of the health services provider’s stock valued at $45,760,000 after buying an additional 297,129 shares during the last quarter. 93.29% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “MAXIMUS, Inc. (MMS) Insider Mark Andrekovich Sells 7,795 Shares” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/maximus-inc-mms-insider-mark-andrekovich-sells-7795-shares/2664323.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.

Featured Article: How Do Tariffs Affect Trade Balances?

Insider Buying and Selling by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.